Latest papers

Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.

Access to medicines versus access to treatment: the case of type 1 diabetes.

Drug donations: what lies beneath.

Early access to new medicines.

[Right to health litigations: a discussion on the observance of the principles of Brazil's Health System].

Providing affordable essential medicines to African households: the missing policies and institutions for price containment.

Think globally, prescribe locally: how rational pharmaceutical policy in the U.S. can improve global access to essential medicines.

The GO License: only part of the solution.

Thirty years of essential medicines in primary health care.

[Drugs and the market]

Brand and generic medications: are they interchangeable?

The selection and use of essential medicines.

Therapeutic drug use in Bangladesh: policy versus practice.

The essential medicines list for a global patient population.

Drug prescribing pattern at the medical outpatient clinic of a tertiary hospital in southwestern Nigeria.

Effects of essential medicines on cardiovascular products available for the market in Thailand.

The morally uncomfortable global drug gap.

Access to essential medicines for children: the world health organization's global response.

Essential medicines for the whole world.

Pharmaceuticals and the strategic national stockpile program.